Sage Therapeutic Stock Analysis
| SAGE Stock | USD 7.35 0.02 0.27% |
Sage Therapeutic is overvalued with Real Value of 5.67 and Hype Value of 7.35. The main objective of Sage Therapeutic stock analysis is to determine its intrinsic value, which is an estimate of what Sage Therapeutic is worth, separate from its market price. There are two main types of Sage Therapeutic's stock analysis: fundamental analysis and technical analysis.
The Sage Therapeutic stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Sage Therapeutic's ongoing operational relationships across important fundamental and technical indicators.
Sage |
Sage Stock Analysis Notes
About 81.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.81. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Sage Therapeutic has Price/Earnings To Growth (PEG) ratio of 0.74. The entity recorded a loss per share of 5.57. The firm had not issued any dividends in recent years. Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Sage Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts. Sage Therapeutic operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 471 people. To find out more about Sage Therapeutic contact Barry Greene at 617 299 8380 or learn more at https://www.sagerx.com.Sage Therapeutic Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Sage Therapeutic's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Sage Therapeutic or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Sage Therapeutic is way too risky over 90 days horizon | |
| Sage Therapeutic appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 86.45 M. Net Loss for the year was (541.49 M) with loss before overhead, payroll, taxes, and interest of (159.16 M). | |
| Sage Therapeutic currently holds about 1.51 B in cash with (540.59 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 25.47, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 81.0% of the company shares are owned by institutional investors |
Sage Therapeutic Upcoming and Recent Events
| 15th of February 2024 Upcoming Quarterly Report | View | |
| 7th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 15th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Sage Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 449.62 M.Technical Drivers
As of the 31st of January, Sage Therapeutic has the Semi Deviation of 2.97, coefficient of variation of 1090.04, and Risk Adjusted Performance of 0.0852. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Sage Therapeutic, as well as the relationship between them. Please validate Sage Therapeutic treynor ratio, and the relationship between the variance and potential upside to decide if Sage Therapeutic is priced more or less accurately, providing market reflects its prevalent price of 7.35 per share. Given that Sage Therapeutic has jensen alpha of 0.5718, we advise you to double-check Sage Therapeutic's current market performance to make sure the company can sustain itself at a future point.Sage Therapeutic Price Movement Analysis
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Sage Therapeutic middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Sage Therapeutic. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Sage Therapeutic Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Sage Therapeutic insiders, such as employees or executives, is commonly permitted as long as it does not rely on Sage Therapeutic's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Sage Therapeutic insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Sage Therapeutic Outstanding Bonds
Sage Therapeutic issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Sage Therapeutic uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Sage bonds can be classified according to their maturity, which is the date when Sage Therapeutic has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| SFCCN 53 13 MAY 28 Corp BondUS78669QAA85 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View |
Sage Therapeutic Predictive Daily Indicators
Sage Therapeutic intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Sage Therapeutic stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Sage Therapeutic Forecast Models
Sage Therapeutic's time-series forecasting models are one of many Sage Therapeutic's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Sage Therapeutic's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Sage Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Sage Therapeutic prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Sage shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Sage Therapeutic. By using and applying Sage Stock analysis, traders can create a robust methodology for identifying Sage entry and exit points for their positions.
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Sage Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts. Sage Therapeutic operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 471 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Sage Therapeutic to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Idea Breakdown Now
Idea BreakdownAnalyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
| All Next | Launch Module |
Complementary Tools for Sage Stock analysis
When running Sage Therapeutic's price analysis, check to measure Sage Therapeutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sage Therapeutic is operating at the current time. Most of Sage Therapeutic's value examination focuses on studying past and present price action to predict the probability of Sage Therapeutic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sage Therapeutic's price. Additionally, you may evaluate how the addition of Sage Therapeutic to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |